Malaysia grants conditional approval for CanSino, J&J COVID-19 vaccines
Reuters2021-06-15
KUALA LUMPUR, June 15 (Reuters) - Malaysia's health ministry said on Tuesday it has granted conditional approval for emergency use to the single dose COVID-19 vaccines manufactured by China's CanSino Biologics and U.S. drugmaker Johnson&Johnson.
It has also approved the use of the Pfizer-BioNTech vaccine for recipients aged 12 and above, the ministry said in a statement.
(Reporting by Rozanna Latiff Editing by Ed Davies)
((rozanna.latiff@thomsonreuters.com; +61 3 9492 9423 ; Reuters Messaging: @rozlatiff on Twitter))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
